Riskpilot← Back to searchSign inGet full accessUNILABS NORGE AS
ASActiveOrg 981230787Vollsveien 2B, 1366 LysakerDiagnostic imaging services and medical laboratory activities · NACE 8691Est. 1999274 employeeswww.unilabs.no
Revenue 2024
NOK 635,5M
+5% vs 2023
EBITDA margin
23.9%
+6% vs 2023
Equity ratio
39.1%
Financial strength
Net profit 2024
NOK 45M
+54% vs 2023
| Revenue | NOK 635,5M | +5% |
| EBITDA | NOK 152,1M | +6% |
| Net profit | NOK 45M | +54% |
| Total assets | NOK 1,3B | +7% |
| Equity | NOK 503,5M | +10% |
| Employees | 274 | — |
Legal name
UNILABS NORGE AS
Org number
981230787
Legal form
Aksjeselskap
NACE code
8691 · Diagnostic imaging services and medical laboratory activities
Founded
10. november 1999
Share capital
NOK 1 649 381
Employees
274 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Tjenesteytende virksomhet innen helsetoren. Samt hva som står i forbindelse med dette, herunder å delta i andre selskap med lignende virksomhet.
Address
Vollsveien 2B, 1366 Lysaker
Phone
+4721000800
Email
miljolab@unilabs.com
Website
www.unilabs.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 539 000 | 578 308 | 602 396 | 607 237 | 635 496 |
| Staff expenses | −242 226 | −270 104 | −290 420 | −298 698 | −313 050 |
| EBITDA | 168 532 | 183 275 | 159 332 | 143 394 | 152 127 |
| Depreciation & amort. | −94 055 | −92 279 | −89 906 | −79 034 | −66 474 |
| EBIT | 74 477 | 90 996 | 69 426 | 64 360 | 85 652 |
| Net financials | −35 869 | −32 762 | −31 032 | −26 919 | −28 038 |
| Profit before tax | 38 608 | 58 234 | 38 394 | 37 441 | 57 615 |
| Tax | 8 389 | 13 381 | 8 292 | 8 132 | 12 604 |
| Net profit | 30 218 | 44 853 | 30 102 | 29 310 | 45 011 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 152 798 | 1 193 451 | 1 187 297 | 1 206 459 | 1 288 591 |
| Equity | 354 400 | 399 282 | 429 228 | 458 419 | 503 475 |
| Long-term debt | 647 698 | 624 569 | 581 157 | 593 481 | 580 276 |
| Short-term debt | 149 722 | 168 356 | 175 581 | 153 662 | 203 874 |
| Total debt | 797 419 | 792 924 | 756 738 | 747 143 | 784 150 |
EBITDA margin
23.9%
This company
15.8%
Market median
+51% vs market
20202024
Equity ratio
39.1%
This company
38.2%
Market median
+2% vs market
20202024
Return on equity
8.9%
This company
18.4%
Market median
-52% vs market
20202024
Net profit margin
7.1%
This company
8.1%
Market median
-12% vs market
20202024
Asset turnover
0.49×
This company
1.12×
Market median
-56% vs market
20202024
Debt / equity
1.56×
This company
0.62×
Market median
-152% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KK Chief Executive Officer | Chief Executive Officer | 2024 |
AM Deputy Member | Deputy Member | 2025 |
| Former (4) | ||
AH Deputy Member | Deputy Member | 2023 – 2025 |
TB Deputy Member | Deputy Member | 2021 – 2023 |
LA Chief Executive Officer | Chief Executive Officer | 2023 – 2024 |
AP Deputy Member | Deputy Member | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (11) | ||
| Board of Directors | 2023 | |
| Board of Directors | 2025 | |
| Board of Directors | 2023 | |
| Board of Directors | 2025 | |
| Board of Directors | 2026 | |
| Board of Directors | 2024 | |
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Chairman | 2026 | |
| Former (4) | ||
| Board of Directors | 2024 – 2025 | |
| Chairman | 2023 – 2023 | |
| Board of Directors | 2021 – 2023 | |
| Board of Directors | 2023 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Unilabs Sa | Company | 100% | 100% | 2023 |
Unilabs Group Holding Aps | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
UNILABS NORGE AS 
UNILABS LABORATORIEMEDISIN ASBoard members of UNILABS NORGE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anne Helene Reiten | Deputy Member | 0 companies |
| Thore Bæverfjord Isaksen | Deputy Member | 0 companies |
| Laila Aarseth | Chief Executive Officer | 0 companies |
| Kjetil Kollstad | Chief Executive Officer | 0 companies |
| Anna Margareth Skuggevik | Deputy Member | 0 companies |
| Alf Petter Årdal | Deputy Member | 0 companies |
| Shalinee Basak | Board of Directors | 0 companies |
| Helene Lund | Board of Directors | 0 companies |
| Elin Beate Olsen Granheim | Board of Directors | 0 companies |
| Anders Fredrik Breitung | Board of Directors | 0 companies |
| Eva Helena Sixt | Board of Directors | 0 companies |
| Mikaela Ywonne Mars | Board of Directors | 0 companies |
| Sanna Kristina Maria Rydberg | Board of Directors | 0 companies |
| Rannveig Børresen Krane | Chairman | 0 companies |
| Baber Iftekhar Zaheer Qazi | Chairman | 0 companies |
| Fredrik Hoff Eriksen | Board of Directors | 0 companies |
| Samantha Jane Marie Laurent | Board of Directors | 0 companies |
| Anders Børseth Jørstad | Board of Directors | 0 companies |
| Geir Ervik | Board of Directors | 0 companies |
| Alessandre Martin Keller | Chairman | 0 companies |
| Michal Jan Kwiecinski | Chairman | 0 companies |